BAL细胞基因表达预示IPF预后并揭示气道基底细胞参与
该回顾性研究分析三个独立IPF队列共212例患者的BAL转录组,发现1582个基因与死亡率相关,并验证一个九基因签名可预测生存;该签名富集气道基底细胞表达基因,IPF的BAL和组织中气道基底细胞增多,而COPD和结节病未见增多。
要点
- BAL细胞九基因签名在发现队列和两个复制队列中均能预测IPF死亡风险。
- 与死亡相关的BAL基因显著富集气道基底细胞表达基因。
- IPF的BAL和组织中气道基底细胞增多,COPD和结节病未见增多。
核心结论
- BAL细胞基因表达签名可预测IPF患者死亡率,并提高基于临床参数的风险预测准确性。
- 该死亡相关签名提示气道基底细胞在IPF中可能发挥作用。
研究设计与样本
- 回顾性研究分析三个独立IPF队列:Freiburg(德国)、Siena(意大利)和Leuven(比利时),共212例患者。
- 对照包括20名健康志愿者、26例III和IV期结节病患者及29例COPD患者。
- 采用Cox模型和component-wise boosting进行生存分析,并通过免疫组化和流式细胞术检测气道基底细胞。
主要发现
- 在调整年龄和性别后,发现队列中1582个基因在FDR小于0.05水平上预测IPF死亡。
- 九基因签名在Siena队列(P < 0.0032)和Leuven队列(P = 0.0033)中均表现良好。
- nCounter表达分析确认了芯片结果(P < 0.0001)。
- 与死亡相关的BAL基因显著富集气道基底细胞表达基因。
- IPF的BAL和组织中气道基底细胞较对照增多,但COPD或结节病中未见增多。
关键数值与推荐
- 九基因签名在复制队列Siena中P < 0.0032,在Leuven中P = 0.0033。
- nCounter验证芯片结果的P < 0.0001。
- 发现队列中1582个基因预测死亡,FDR小于0.05(调整年龄和性别)。
临床怎么用
- BAL细胞基因表达签名可用于IPF患者生存风险分层,辅助临床预后判断。
- 气道基底细胞增多提示其可能参与IPF发病,需进一步研究验证。
局限性
- 本研究为回顾性分析,样本量有限(IPF共212例)。
- 九基因签名需在前瞻性队列中进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE: Idiopathic pulmonary fibrosis (IPF) is a fatal disease with a variable and unpredictable course. OBJECTIVES: To determine whether BAL cell gene expression is predictive of survival in IPF. METHODS: This retrospective study analyzed the BAL transcriptome of three independent IPF cohorts: Freiburg (Germany), Siena (Italy), and Leuven (Belgium) including 212 patients. BAL cells from 20 healthy volunteers, 26 patients with sarcoidosis stage III and IV, and 29 patients with chronic obstructive pulmonary disease were used as control subjects. Survival analysis was performed by Cox models and component-wise boosting. Presence of airway basal cells was tested by immunohistochemistry and flow cytometry. MEASUREMENTS AND MAIN RESULTS: A total of 1,582 genes were predictive of mortality in the IPF derivation cohort in univariate analyses adjusted for age and sex at false discovery rate less than 0.05. A nine-gene signature, derived from the discovery cohort (Freiburg), performed well in both replication cohorts, Siena (P < 0.0032) and Leuven (P = 0.0033). nCounter expression analysis confirmed the array results (P < 0.0001). The genes associated with mortality in BAL cells were significantly enriched for genes expressed in airway basal cells. Further analyses by gene expression, flow cytometry, and immunohistochemistry showed an increase in airway basal cells in BAL and tissues of IPF compared with control subjects, but not in chronic obstructive pulmonary disease or sarcoidosis. CONCLUSIONS: Our results identify and validate a BAL signature that predicts mortality in IPF and improves the accuracy of outcome prediction based on clinical parameters. The BAL signature associated with mortality unmasks a potential role for airway basal cells in IPF.
引用
- Prasse A, Binder H, Schupp JC, et al. BAL Cell Gene Expression Is Indicative of Outcome and Airway Basal Cell Involvement in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2019. PMID: 30141961. doi:10.1164/rccm.201712-2551OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。